Aytu BioPharma Inc. (AYTU)
NASDAQ · Healthcare
Aytu BioPharma Inc. Shareholder Equity 2014–2025
Aytu BioPharma Inc. annual shareholder equity history from 2014 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Aytu BioPharma Inc. shareholder equity as of June 30, 2025: 19.0M, a 31.57% decrease year-over-year.
- Aytu BioPharma Inc. shareholder equity for 2025 were 19.0M, a 31.57% decrease from 2024.
- Aytu BioPharma Inc. shareholder equity for 2024 were 27.7M, a 29.58% decrease from 2023.
- Aytu BioPharma Inc. shareholder equity for 2023 were 39.4M, a 11.17% decrease from 2022.
- Aytu BioPharma Inc. shareholder equity for 2022 were 44.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Aytu BioPharma Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $19 |
| 2024 | $28 |
| 2023 | $39 |
| 2022 | $44 |
| 2021 | $138 |
| 2020 | $95 |
| 2019 | $7 |
| 2018 | $13 |
| 2017 | $4 |
| 2016 | $10 |
| 2015 | $16 |
| 2014 | $5 |
Aytu BioPharma Inc. Shareholder Equity — FAQ
Aytu BioPharma Inc. (AYTU) shareholder equity over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AYTU's shareholder equity history?
The chart and table above show Aytu BioPharma Inc.'s shareholder equity by year and by quarter, including the growth rate.